January 17, 2025 (Investorideas.com Newswire) Investorideas.com (www.investorideas.com), a go-to platform for big investing ideas for stock traders, including biotech and medical stocks reports on trading and news for Baird Medical…
Investment
-
-
Arafura Rare Earths (ASX:ARU,OTC Pink:ARAFF) said on Wednesday (January 15) that it has signed a binding term sheet for its Nolans rare earths project with the National Reconstruction Fund Corporation…
-
Panacea Financial is a financial services company offering medical student loan refinancing options. If you’ve made it through medical school, there’s a good chance you’ve relied on some amount of…
-
Investment
The Compounded Returns if You Dollar Cost Average into the STI ETF for the past 18 Years.
I was chilling at my desk while clearing leave on this year end break when I suddenly remember about the STI ETF. I used to do a pretty regular update…
-
Humans like to find patterns in things that we do, leading to enduring interest in seasonal trends within the stock market. One of the most well-known of these is the…
-
January 15, 2025 (Investorideas.com Newswire) Investorideas.com, a go-to platform for big investing ideas releases market commentary from Quasar Elizundia, Expert Research Strategist at Pepperstone. “The Mexican peso has…
-
Investment
CleanTech Lithium PLC Submits Application for a Special Lithium Operating Contract (CEOL) for its Laguna Verde Project in Chile
The Company has made significant progress with the Pre-Feasibility Study (“PFS“) at the flagship project, Laguna Verde, and seen encouraging results from the Direct Lithium Extraction (“DLE”) pilot plant in…
-
Grants for college are a source of financial aid that’s effectively free money. Unlike scholarships, grants are aid that is offered from the government – usually the Federal government or…
-
By Egon von Greyerz There is a fine line between happiness and misery, as Dickens describes in David Copperfield. Copperfield’s landlord, Mr Micawber, was just on the wrong side of happiness…
-
Today’s data research probably concerns those folks who invest in constant-duration fixed income bond funds. This is probably not for those who bought bond funds where the fund managers actively…
